Mariposa Diagnostics plans to transform the process of diagnosing lupus while accelerating the pace of new therapeutic developments for this under-diagnosed and underserved disorder. A University of Michigan spin-out, Mariposa will offer proprietary clinical diagnostic testing as well as contract research services for pharmaceutical companies looking to outsource development efforts on early-stage drug candidates for lupus.